General Information


DRACP ID  DRACP04482

Peptide Name  

Sequence  GGGGGGGRGDLPETGGS

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C53H86N20O24

Absent amino acids  ACFHIKMNQVWY

Common amino acids  G

Mass  167296

Pl  4.18

Basic residues  1

Acidic residues  2

Hydrophobic residues  1

Net charge  -1

Boman Index  -2210

Hydrophobicity  -87.06

Aliphatic Index  22.94

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28351594

Title  New potent and selective 伪v尾3 integrin ligands: Macrocyclic peptides containing RGD motif synthesized by sortase A-mediated ligation

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20071

DRACP is developed by Dr.Zheng's team.